-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Centiva Capital LP Grows Stake in BioPlus Acquisition Corp. (NASDAQ:BIOS)
Centiva Capital LP Grows Stake in BioPlus Acquisition Corp. (NASDAQ:BIOS)
Centiva Capital LP lifted its position in BioPlus Acquisition Corp. (NASDAQ:BIOS – Get Rating) by 3.3% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 103,250 shares of the company's stock after buying an additional 3,250 shares during the period. Centiva Capital LP owned approximately 0.35% of BioPlus Acquisition worth $1,038,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also recently modified their holdings of BIOS. Highbridge Capital Management LLC purchased a new position in shares of BioPlus Acquisition in the 1st quarter worth $11,719,000. Goldman Sachs Group Inc. purchased a new position in BioPlus Acquisition during the first quarter valued at $8,152,000. Polar Asset Management Partners Inc. purchased a new position in BioPlus Acquisition during the first quarter valued at $7,410,000. MMCAP International Inc. SPC purchased a new position in BioPlus Acquisition during the first quarter valued at $6,422,000. Finally, Starboard Value LP purchased a new position in BioPlus Acquisition during the first quarter valued at $6,098,000. 65.67% of the stock is currently owned by hedge funds and other institutional investors.
Get BioPlus Acquisition alerts:BioPlus Acquisition Trading Up 0.1 %
NASDAQ BIOS opened at $10.20 on Monday. The business's fifty day moving average is $10.13 and its 200 day moving average is $10.03. BioPlus Acquisition Corp. has a fifty-two week low of $9.78 and a fifty-two week high of $10.20.
About BioPlus Acquisition
(Get Rating)BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.
Further Reading
- Get a free copy of the StockNews.com research report on BioPlus Acquisition (BIOS)
- Dave & Buster's Proves Experiential Dining Demand is Strong
- Does Lululemon's 12% Drop Signal Bad News For Clothing Retailers?
- MarketBeat: Week in Review 12/05 – 12/09
- There Is Fundamental Value In Broadcom, And It Yields 3.35%
- Costco vs Amazon: an end of the year showdown
Want to see what other hedge funds are holding BIOS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BioPlus Acquisition Corp. (NASDAQ:BIOS – Get Rating).
Receive News & Ratings for BioPlus Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPlus Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
Centiva Capital LP lifted its position in BioPlus Acquisition Corp. (NASDAQ:BIOS – Get Rating) by 3.3% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 103,250 shares of the company's stock after buying an additional 3,250 shares during the period. Centiva Capital LP owned approximately 0.35% of BioPlus Acquisition worth $1,038,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Centiva Capital LP在提交给美国证券交易委员会(SEC)的最新文件中称，该公司在第二季度将其在BioPlus收购公司(纳斯达克：Bios-Get Rating)的持仓提高了3.3%。该基金持有103,250股该公司股票，在此期间又购买了3,250股。截至最近提交给美国证券交易委员会(SEC)的文件，Centiva Capital LP拥有BioPlus收购约0.35%的股份，价值1,038,000美元。
A number of other institutional investors and hedge funds have also recently modified their holdings of BIOS. Highbridge Capital Management LLC purchased a new position in shares of BioPlus Acquisition in the 1st quarter worth $11,719,000. Goldman Sachs Group Inc. purchased a new position in BioPlus Acquisition during the first quarter valued at $8,152,000. Polar Asset Management Partners Inc. purchased a new position in BioPlus Acquisition during the first quarter valued at $7,410,000. MMCAP International Inc. SPC purchased a new position in BioPlus Acquisition during the first quarter valued at $6,422,000. Finally, Starboard Value LP purchased a new position in BioPlus Acquisition during the first quarter valued at $6,098,000. 65.67% of the stock is currently owned by hedge funds and other institutional investors.
其他一些机构投资者和对冲基金最近也调整了对基本输入输出系统的持股。Highbridge Capital Management LLC在第一季度购买了BioPlus收购的新头寸，价值11,719,000美元。高盛股份有限公司在第一季度购买了BioPlus收购的一个新头寸，价值8,152,000美元。Polal Asset Management Partners Inc.在第一季度购买了BioPlus收购的新头寸，价值7,410,000美元。MmCap International Inc.SPC在第一季度购买了BioPlus收购的一个新头寸，价值642.2万美元。最后，Starboard Value LP在第一季度购买了BioPlus收购的新头寸，价值6,098,000美元。65.67%的股票目前由对冲基金和其他机构投资者持有。
BioPlus Acquisition Trading Up 0.1 %
BioPlus收购交易上涨0.1%
NASDAQ BIOS opened at $10.20 on Monday. The business's fifty day moving average is $10.13 and its 200 day moving average is $10.03. BioPlus Acquisition Corp. has a fifty-two week low of $9.78 and a fifty-two week high of $10.20.
纳斯达克基本输入输出系统周一开盘报10.2美元。该业务的50日移动均线切入位为10.13美元，200日移动均线切入位为10.03美元。BioPlus Acquisition Corp.的股价为52周低点9.78美元，52周高点10.20美元。
About BioPlus Acquisition
关于收购BioPlus
BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.
BioPlus收购公司没有重要的业务。拟与生命科学行业的一项或多项业务进行合并、股份交换、资产收购、股份购买、重组或其他类似业务合并。该公司成立于2021年，总部设在纽约。
Further Reading
进一步阅读
- Get a free copy of the StockNews.com research report on BioPlus Acquisition (BIOS)
- Dave & Buster's Proves Experiential Dining Demand is Strong
- Does Lululemon's 12% Drop Signal Bad News For Clothing Retailers?
- MarketBeat: Week in Review 12/05 – 12/09
- There Is Fundamental Value In Broadcom, And It Yields 3.35%
- Costco vs Amazon: an end of the year showdown
- 免费获取StockNews.com关于BioPlus收购(BIOS)的研究报告
- Dave&Buster‘s证明体验式用餐需求强劲
- Lululemon 12%的降幅对服装零售商来说是坏消息吗？
- MarketBeat：回顾一周12/05-12/09
- 博通有基本面价值，收益率为3.35%
- 好市多VS亚马逊：年底摊牌
Want to see what other hedge funds are holding BIOS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BioPlus Acquisition Corp. (NASDAQ:BIOS – Get Rating).
想看看还有哪些对冲基金持有基本输入输出系统吗？访问HoldingsChannel.com获取BioPlus收购公司(纳斯达克：Bios-Get Rating)的最新13F文件和内幕交易。
Receive News & Ratings for BioPlus Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPlus Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
每日收到BioPlus收购的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对BioPlus收购和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧